FDA clears Boston's Express biliary stent:
This article was originally published in Clinica
Executive Summary
Boston Scientific has received US FDA 510(k) clearance to market its Express Biliary SD Monorail premounted stent system for treating malignant biliary tumours combines Boston's Express stent and Maveric balloon catheter to provide "excellent trackability and deliverability, without compromising stent radial strength", claims the company, which plans to launch the system immediately.